shutterstock.com
Feb 26, 2025, 10:09
No evidence to suggest that CAR T cell therapy leads to secondary cancers
Cancer Research Institute posted on LinkedIn.
“A study of over 700 patients treated with CAR T cell therapy, conducted by Penn Medicine, University of Pennsylvania Health System researchers, found no evidence that the therapy itself caused any type of secondary cancer in the modified T cells.
‘As we develop new cancer therapies, patient safety is always our top priority,’ says the study’s co-senior author, CRI Scientific Advisory Council member, Dr. Carl June. ‘We know that all cancer treatments come with some form of risk, and we aim to continue to make CAR T cell therapy even safer and more effective, so that more patients and their families can benefit from this lifesaving therapy.'”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 26, 2025, 10:09
Feb 26, 2025, 10:06
Feb 26, 2025, 10:02
Feb 26, 2025, 10:01
Feb 26, 2025, 09:56
Feb 26, 2025, 09:50
Feb 26, 2025, 09:46
Feb 26, 2025, 09:43
Feb 26, 2025, 09:41